Conatus Pharmaceuticals Inc. buy Mori8
Start price
26.09.18
/
50%
€49.60
Target price
03.06.19
€65.00
Performance (%)
-85.73%
End price
03.06.19
€7.08
Summary
This prediction ended on 03.06.19 with a price of €7.08. Massive losses of -85.73% were the result for the BUY prediction by Mori8. Mori8 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Conatus Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | -0.543% | 1.491% | 13.638% | 16.760% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% | 45.155% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% | 7.840% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% | 43.056% |
Comments by Mori8 for this prediction
In the thread Conatus Pharmaceuticals Inc. diskutieren
Mori8 stimmt der Buy-Einschätzung von Quitte zu
Mori8 stimmt am 26.09.2018 der Buy-Einschätzung von Quitte mit dem Kursziel 6,5$ zu.
Überschrift: Wiedereinstieg
(Vom Mitglied beendet)
Stopped prediction by Mori8 for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.18
16.04.20
16.04.20
€8.00
04.11.21
04.11.21
-81.19%
19.10.21
19.10.21
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.91
29.06.19
29.06.19
€4.80
11.03.20
11.03.20
8.84%
11.03.20
11.03.20
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.30
27.06.19
27.06.19
€4.80
28.06.19
28.06.19
0.00%
28.06.19
28.06.19